Neurobehavioral health company BlackThorn pulls in $76 million from GV to treat mental disorders

There are numerous challenges to finding effective treatments for mental disorders. However, BlackThorn Therapeutics, a neurobehavioral health company using machine learning to create personalized medicine for mental health, is betting its technological approach to finding drugs that work will put it ahead of the competition. Lucky for them, GV and other biotech investors have shown […]

Groupon co-founder Eric Lefkofsky just raised another $200 million for his newest company, Tempus

When serial entrepreneur Eric Lefkofsky grows a company, he puts the pedal to the metal. When in 2011 his last company, the Chicago-based coupons site Groupon, raised $950 million from investors, it was the largest amount raised by a startup ever. It was just over three years old at the time, and it went public […]

As researchers pursue links between bacteria and human health, startups stand to benefit

In 2009, the National Institutes of Health launched a five-year, $150 million project to stimulate research into a new field of medicine examining the connections between the millions of bacteria living in the human gut and overall human health. Spurred by the advancements in genetics from a decade earlier, this new field of research would […]

On the heels of a $40 million round, TriNetX brings its services for drug trials to Europe

The market for technology and services for clinical drug trials is expected to reach $68.9 billion over the next seven years. The trials, which are necessary to bring new healthcare treatments to market, are by necessity prolonged, complicated affairs. Several companies are vying for a piece of this multi-billion-dollar pie with the offer of new […]